Kimberly Ma

Kim has over 17 years of clinical research experience in the biotech/pharmaceutical industry. Prior to joining RayzeBio, Kim served as Senior Vice President, Clinical Operations at Odonate Therapeutics where she led an in-house clinical operations team in running multiple clinical trials in metastatic breast cancer (Phases 1-3). From 2014 to 2017, Kim was Director, Clinical Project Management at Pfizer, and led cross-functional teams for several early development trials in Pfizer’s oncology portfolio. Prior to Pfizer, Kim held positions of increasing responsibility at various CRO and Sponsor companies, including Medtronic Diabetes, ICON plc, and PPD.

Kim earned her Masters of Science in Regulatory Science from the University of Southern California (USC) School of Pharmacy and her Bachelors of Science in Biomedical Engineering from the USC Viterbi School of Engineering.